Link
- Argentinean Network of Women Living with HIV-AIDS
- Asia Pacific Network of People Living with HIV/AIDS
- bilaterals.org
- Cambodian People Living with HIV/AIDS Network (CPN+)
- Delhi Network of Positive People (DNP+)
- Essentialdrugs.org
- FACEBOOK PAGE: Stop the EU India Free Trade Agreement
- FTA Malaysia
- Health Action International – Asia Pacific
- Intellectual Property Watch
- Lawyers Collective HIV/AIDS Unit
- MSF Access Campaign
- National Association of People Living with HIV and AIDS in Nepal (NAPN)
- Public Citizen
- Stop Peru FTA
- Thai Network of People Living with HIV/Aids (TNP+)
- Third World Network
Take Action
Archives
-
Recent Posts
- The Cost of Price: Why and How to Get Beyond Intellectual Property Internalism
- WHA 65 adopted the resolution for way forward on CEWG report on R&D
- Corporations Win Big in Battle Against Investment Regulation
- US and EU Derailing Ten-year Process to Create Health Research & Development Convention
- MSF: Update on debates at World Health Assembly on a possible R&D convention, 23 May 2012
Categories
Tag Archives: Aids
Oxfam calls on EU not to shut down ‘pharmacy of the developing world’
“At a time of declining aid budgets, efforts to increase medicine prices for the world’s poor would have a devastating impact on the achievement of health-related Millennium Development Goals.” Rohit Malpani Oxfam Policy Advisor Published: 9 February 2012 On the … Continue reading
Posted in EU-India FTA, Generic drug, Millenium Development Goals
Tagged Aids, Elton John, European Union, Oxfam
Leave a comment
A Trade Barrier to Defeating AIDS
By TINA ROSENBERG July 26, 2011 Earlier this month, the patent pool received its first donation of rights from a pharmaceutical manufacturer, Gilead Sciences. It is an important step — but the terms Gilead negotiated are also confirmation of a … Continue reading
Medicine Patent Pool’s agreement with Gilead: Is it really a fair deal?
Recently, Medicine Patent Pool signed its first agreement with pharmaceutical company Gilead for the production of the HIV medicines tenofovir, emtricitabine, cobicistat, and elvitegravir as well as a combination of these products in a single pill known as the “Quad.” Click … Continue reading
Posted in Generic drug, HIV/Aids, Medicine Patent Pool
Tagged Aids, Generic drug, Gilead Sciences, HIV, Patent pool, Tenofovir, Unitaid
Leave a comment
Global Access Licensing as means to increase access to medicines
Read here an interesting blog article by UAEM suggesting Global Access Licensing as means for ensuring that public funded research on medical innovation reaches to people living in the developing countries on affordable prices. Global Access Licensing would allow generic … Continue reading
AIDS Fight Hits Hurdle Over Funding
Global Economy Crimps Contributions to Developing Nations for Drugs Recently Shown to Curb Spread Wall Street Journal By BETSY MCKAY And MARK SCHOOFS In advance of a major United Nations meeting on the global AIDS epidemic, public-health leaders face a … Continue reading
